COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality –cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM)-Reference-Cited by-同舟云学术

COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality –cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM)

Published:2023-09 Issue: Volume: Page:
ISSN:2531-1379
Container-title:Hematology, Transfusion and Cell Therapy
language:en
Short-container-title:Hematology, Transfusion and Cell Therapy

Author:

Garnica Marcia^ORCID,Crusoe Edvan De Queiroz^ORCID,Ribeiro Glaciano^ORCID,Bittencourt Rosane,Magalhães Roberto José Pessoa^ORCID,Zanella Karla Richter^ORCID,Hallack Neto Abrahão Elias^ORCID,Lima Juliana Souza,Solo Caroline Bonamin,Souza Emmanuella Graciott^ORCID,Fernandes Andre Magalhaes^ORCID,Maiolino Angelo,Hungria Vania^ORCID

Publisher

Elsevier BV

Subject

Hematology,Immunology and Allergy

Reference23 articles.

1. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients;Blimark;Haematologica,2015

2. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents;Nucci;Clin Infect Dis,2009

3. Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy;Teh;Br J Haematol,2015

4. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study;Lee;Lancet,2020

5. Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period;Neparidze;Leukemia,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights;Clinical and Experimental Medicine;2024-06-04

2. Are we securing our future workforce of physician-scientists in hematology?;Hematology, Transfusion and Cell Therapy;2024-04